Catheter Precision, Inc. Files 8-K on Shareholder Vote Matters

TL;DR

CATR filed an 8-K for shareholder vote matters as of Oct 10.

AI Summary

Catheter Precision, Inc. filed an 8-K on October 15, 2025, reporting on matters submitted to a vote of security holders as of October 10, 2025. The company, formerly known as Ra Medical Systems, Inc., is incorporated in Delaware and operates in the surgical and medical instruments sector.

Why It Matters

This filing indicates important corporate actions or decisions that have been put before the company's shareholders for a vote, which could impact the company's future direction.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not inherently present new financial or operational risks.

Key Numbers

• 001-38677 — SEC File Number (Identifies the company's filing with the SEC.)
• 38-3661826 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Catheter Precision, Inc. (company) — Registrant
• Ra Medical Systems, Inc. (company) — Former company name
• October 10, 2025 (date) — Date of earliest event reported
• October 15, 2025 (date) — Filing date
• Delaware (jurisdiction) — State of incorporation
• 3841 (sic_code) — Standard Industrial Classification

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock , par value $0.0001 per share VTAK NYSE American Indica

Filing Documents

• vtak20251013_8k.htm (8-K) — 37KB
• 0001437749-25-031036.txt ( ) — 168KB
• vtak-20251010.xsd (EX-101.SCH) — 3KB
• vtak-20251010_def.xml (EX-101.DEF) — 12KB
• vtak-20251010_lab.xml (EX-101.LAB) — 15KB
• vtak-20251010_pre.xml (EX-101.PRE) — 12KB
• vtak20251013_8k_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On October 10, 2025, the Company held a Special Meeting of stockholders at which, of the 1,487,266 shares of the Company's common stock outstanding as of September 10, 2025, the record date for the Annual Meeting, 641,616 shares of common stock were represented, either in person or by proxy, constituting, of the shares entitled to vote, approximately 43.1% of the outstanding shares of common stock. At the Annual Meeting, the Company's stockholders considered three proposals, which are described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on September 15, 2025. The matters voted on at the Annual Meeting and the votes cast with respect to each such matter are set forth below: 1. Proposal No. 1: To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of our common stock from sixty (60) million shares to five hundred (500) million shares. Proposal No. 1 was approved, based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 497,162 133,882 10,571 0 2. Proposal No. 2: To ratify the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2026. Proposal No. 2 was approved, based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 610,134 16,778 14,703 0 3. Proposal No. 3: To approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposals Nos 1 and/or 2. Proposal No. 3 was approved, based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 514,362 120,394 6,860 0

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: October 15, 2025 By: /s/ Philip Anderson Philip Anderson Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR